Protein domain-based prediction of drug/compound-target interactions and experimental validation on LIM kinases.

PLoS Comput Biol · 2021 · PMC8659301 · PMID 34843456

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Among these derivative compounds, LIMKi-2c and LIMKi-2d displayed highly significant anti-migratory and anti-invasive properties on liver cancer cells, together with strong docking binding affinities.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.